Search

Your search keyword '"Kollmannsberger, C."' showing total 649 results
Start Over Author "Kollmannsberger, C."
649 results on '"Kollmannsberger, C."'

106. Maintaining success, reducing treatment burden, focusing on survivorship: Highlights from the third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer

Author

Beyer, J. (Jörg), Albers, P. (Peter), Altena, R. (Renske), Aparicio, J. (Jorge), Bokemeyer, C., Busch, J. (Jamie), Cathomas, R. (Richard), Cavallin-Stahl, E. (Eva), Clarke, N.W. (Noel), Claßen, J. (Johannes), Cohn-Cedermark, G. (Gabriella), Dahl, A.A., Daugaard, G. (Gedske), Giorgi, U. (Ugo) de, Santis, M. (Maria) de, De Wit, M. (Meike), Wit, R. (Ronald) de, Dieckmann, K.P., Fenner, M. (Martin), Fizazi, K. (Karim), Flechon, A. (Aude), Fossa, S.D. (Sophie), Germá Lluch, J.R. (José Ramón), Gietema, J.A. (Jourik), Gillessen, S. (Silke), Giwercman, A. (Aleksander), Hartmann, J.T., Heidenreich, A. (Axel), Hentrich, M. (Marcus), Honecker, F.U. (Friedemann), Horwich, A., Huddart, R.A. (Robbert), Kliesch, S. (Sabine), Kollmannsberger, C. (Christian), Krege, S. (Susanne), Laguna, M.P. (Maria Pilar), Looijenga, L.H.J. (Leendert), Lorch, A. (Anja), Lotz, J.P. (Jean Pierre), Mayer, F., Necchi, A. (Andrea), Nicolai, N. (Nicola), Nuver, J. (Janine), Oechsle, K. (Karin), Oldenburg, J. (Jan), Oosterhuis, J.W. (Wolter), Powles, T. (Tom), Rajpert-De Meyts, E. (Ewa), Rick, O. (Oliver), Rosti, G. (Giovanni), Salvioni, R. (Roberto), Winter, C.G. (Christopher), Wittekind, C. (Christian), Beyer, J. (Jörg), Albers, P. (Peter), Altena, R. (Renske), Aparicio, J. (Jorge), Bokemeyer, C., Busch, J. (Jamie), Cathomas, R. (Richard), Cavallin-Stahl, E. (Eva), Clarke, N.W. (Noel), Claßen, J. (Johannes), Cohn-Cedermark, G. (Gabriella), Dahl, A.A., Daugaard, G. (Gedske), Giorgi, U. (Ugo) de, Santis, M. (Maria) de, De Wit, M. (Meike), Wit, R. (Ronald) de, Dieckmann, K.P., Fenner, M. (Martin), Fizazi, K. (Karim), Flechon, A. (Aude), Fossa, S.D. (Sophie), Germá Lluch, J.R. (José Ramón), Gietema, J.A. (Jourik), Gillessen, S. (Silke), Giwercman, A. (Aleksander), Hartmann, J.T., Heidenreich, A. (Axel), Hentrich, M. (Marcus), Honecker, F.U. (Friedemann), Horwich, A., Huddart, R.A. (Robbert), Kliesch, S. (Sabine), Kollmannsberger, C. (Christian), Krege, S. (Susanne), Laguna, M.P. (Maria Pilar), Looijenga, L.H.J. (Leendert), Lorch, A. (Anja), Lotz, J.P. (Jean Pierre), Mayer, F., Necchi, A. (Andrea), Nicolai, N. (Nicola), Nuver, J. (Janine), Oechsle, K. (Karin), Oldenburg, J. (Jan), Oosterhuis, J.W. (Wolter), Powles, T. (Tom), Rajpert-De Meyts, E. (Ewa), Rick, O. (Oliver), Rosti, G. (Giovanni), Salvioni, R. (Roberto), Winter, C.G. (Christopher), and Wittekind, C. (Christian)

Abstract

In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands) [Schmoll H-J, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ-cell cancer: a report of the European Germ-Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-1399; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478-496; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part II. Eur Urol 2008; 53: 497-513]. A panel of 56 of 60 invited GCC experts from all across Europe discussed all aspects on diagnosis and treatment of GCC, with a particular focus on acute and late toxic effects as well as on survivorship issues. The panel consisted of oncologists, urologic surgeons, radiooncologists, pathologists and basic scientists, who are all actively involved in care of GCC patients. Panelists were chosen based on the publication activity in recent years. Before the meeting, panelists were asked to review the literature published since 2006 in 20 major areas concerning all aspects of diagnosis, treatment and follow-up of GCC patients, and to prepare an updated version of the previous recommendations to be discussed at the conference. In addition, ̃50 E-vote questions were drafted and presented at the conference to address the most controversial areas for a poll of expert opinions. Here, we present the main recommendations and controversies of this meeting. The votes of the panelists are added as online supplements. © The Author 2012. Published by Oxford Univer

Published
2013
Full Text
View/download PDF

107. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

Author

Beyer, J, Albers, P, van Altena, R, Aparicio, J, Bokemeyer, C, Busch, J, Cathomas, R, Cavallin-Stahl, E, Clarke, NW, Classen, J, Cohn-Cedermark, G, Dahl, AA, Daugaard, G, De Giorgi, U, De Santis, M, de Wit, M, de Wit, Ronald, Dieckmann, KP, Fenner, M, Fizazi, K, Flechon, A, Fossa, SD, Lluch, JRG, Gietema, JA, Gillessen, S, Giwercman, A, Hartmann, JT, Heidenreich, A, Hentrich, M, Honecker, F, Horwich, A, Huddart, RA, Kliesch, S, Kollmannsberger, C, Krege, S, Laguna, MP, Looijenga, LHJ (Leendert), Lorch, A, Lotz, JP, Mayer, Frenchey, Necchi, A, Nicolai, N, Nuver, J, Oechsle, K, Oldenburg, J, Oosterhuis, Wolter, Powles, T, Rajpert-De Meyts, E, Rick, O, Rosti, G, Salvioni, R, Schrader, M, Schweyer, S, Sedlmayer, F, Sohaib, A, Souchon, R, Tandstad, T, Winter, C, Wittekind, C, Beyer, J, Albers, P, van Altena, R, Aparicio, J, Bokemeyer, C, Busch, J, Cathomas, R, Cavallin-Stahl, E, Clarke, NW, Classen, J, Cohn-Cedermark, G, Dahl, AA, Daugaard, G, De Giorgi, U, De Santis, M, de Wit, M, de Wit, Ronald, Dieckmann, KP, Fenner, M, Fizazi, K, Flechon, A, Fossa, SD, Lluch, JRG, Gietema, JA, Gillessen, S, Giwercman, A, Hartmann, JT, Heidenreich, A, Hentrich, M, Honecker, F, Horwich, A, Huddart, RA, Kliesch, S, Kollmannsberger, C, Krege, S, Laguna, MP, Looijenga, LHJ (Leendert), Lorch, A, Lotz, JP, Mayer, Frenchey, Necchi, A, Nicolai, N, Nuver, J, Oechsle, K, Oldenburg, J, Oosterhuis, Wolter, Powles, T, Rajpert-De Meyts, E, Rick, O, Rosti, G, Salvioni, R, Schrader, M, Schweyer, S, Sedlmayer, F, Sohaib, A, Souchon, R, Tandstad, T, Winter, C, and Wittekind, C

Published
2013

108. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

Author

Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Stahl, E., Classen, J., Clemm, C., Cohn-Cedermark, G., Culine, S., Daugaard, G., Mulder, P.H.M. de, Santis, M. de, Wit, M. de, Wit, R. de, Derigs, H.G., Dieckmann, K.P., Dieing, A., Droz, J.P., Fenner, M., Fizazi, K., Flechon, A., Fossa, S.D., Muro, X.G. del, Gauler, T., Geczi, L., Gerl, A., Germa-Lluch, J.R., Gillessen, S., Hartmann, J.T., Hartmann, M., Heidenreich, A., Hoeltl, W., Horwich, A., Huddart, R., Jewett, M., Joffe, J., Jones, W., Kisbenedek, L., Klepp, O., Kliesch, S., Koehrmann, K.U., Kollmannsberger, C., Kuczyk, M.A., Laguna, P.M., Galvis, O.L., Loy, V., Mason, M.D., Mead, G.M., Mueller, R., Nichols, C., Nicolai, N., Oliver, T., Ondrus, D., Oosterhof, G.O.N., Paz-Ares, L., Pizzocaro, G., Pont, J.J.H.H.M. de, Pottek, T., Powles, T., Rick, O., Rosti, G., Salvioni, R., Scheiderbauer, J., Schmelz, H.U., Schmidberger, H., Schmoll, H.J., Schrader, M., Sedlmayer, F., Skakkebaek, N.E., Sohaib, A., Tjulandin, S., Warde, P., Weinknecht, S., Weissbach, L., Wittekind, C., Winter, E., Wood, L., Maase, H. von der, Krege, S., Beyer, J., Souchon, R., Albers, P., Albrecht, W., Algaba, F., Bamberg, M., Bodrogi, I., Bokemeyer, C., Cavallin-Stahl, E., Classen, J., Clemm, C., Cohn-Cedermark, G., Culine, S., Daugaard, G., Mulder, P.H.M. de, Santis, M. de, Wit, M. de, Wit, R. de, Derigs, H.G., Dieckmann, K.P., Dieing, A., Droz, J.P., Fenner, M., Fizazi, K., Flechon, A., Fossa, S.D., Muro, X.G. del, Gauler, T., Geczi, L., Gerl, A., Germa-Lluch, J.R., Gillessen, S., Hartmann, J.T., Hartmann, M., Heidenreich, A., Hoeltl, W., Horwich, A., Huddart, R., Jewett, M., Joffe, J., Jones, W., Kisbenedek, L., Klepp, O., Kliesch, S., Koehrmann, K.U., Kollmannsberger, C., Kuczyk, M.A., Laguna, P.M., Galvis, O.L., Loy, V., Mason, M.D., Mead, G.M., Mueller, R., Nichols, C., Nicolai, N., Oliver, T., Ondrus, D., Oosterhof, G.O.N., Paz-Ares, L., Pizzocaro, G., Pont, J.J.H.H.M. de, Pottek, T., Powles, T., Rick, O., Rosti, G., Salvioni, R., Scheiderbauer, J., Schmelz, H.U., Schmidberger, H., Schmoll, H.J., Schrader, M., Sedlmayer, F., Skakkebaek, N.E., Sohaib, A., Tjulandin, S., Warde, P., Weinknecht, S., Weissbach, L., Wittekind, C., Winter, E., Wood, L., and Maase, H. von der

Abstract

Item does not contain fulltext, OBJECTIVES: The first consensus report that had been presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the auspices of the Department of Urology of the Amsterdam Medical Center, The Netherlands. METHODS: Medical oncologists, urologic surgeons, radiation oncologists as well as pathologists from several European countries reviewed and discussed the data that had emerged since the 2002 conference and incorporated the new data into updated and revised guidelines. As for the first meeting the methodology of evidence-based medicine (EBM) was applied. The results of the discussion were compiled by the writing committee. All participants have agreed to this final update. RESULTS: The second part of the consensus paper includes the treatment of metastasised disease, residual tumour resection, salvage therapy, follow-up, and late toxicities. CONCLUSIONS: Whereas the vast majority of the recommendations made in 2004 remain valid 3 yr later, refinements in the treatment of early-stage as well as of advanced-stage testicular cancer have emerged from clinical trials. Despite technical improvements, expert clinical skills will continue to be one of the major determinants for the prognosis of patients with germ cell cancer. In addition, the particular needs of testicular cancer survivors have been acknowledged.

Published
2008

110. Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer

Author

Chi, K. N., primary, Tolcher, A., additional, Lee, P., additional, Rosen, P. J., additional, Kollmannsberger, C. K., additional, Papadopoulos, K. P., additional, Patnaik, A., additional, Molina, A., additional, Jiao, J., additional, Pankras, C., additional, Kaiser, B., additional, Bernard, A., additional, Tran, N., additional, and Acharya, M., additional

Published
2012
Full Text
View/download PDF

114. Progression-Free Survival as a Clinical Trial Endpoint in Advanced Renal Cell Carcinoma

Author

Hotte, S.J., primary, Bjarnason, G.A., additional, Heng, D.Y.C., additional, Jewett, M.A.S., additional, Kapoor, A., additional, Kollmannsberger, C., additional, Maroun, J., additional, Mayhew, L.A., additional, North, S., additional, Reaume, M.N., additional, Ruether, J.D., additional, Soulieres, D., additional, Venner, P.M., additional, Winquist, E.W., additional, Wood, L., additional, Yong, J.H.E., additional, and Saad, F., additional

Published
2011
Full Text
View/download PDF

118. Phase II trial of linifanib in patients (pts) with advanced renal cell carcinoma (RCC): Analysis of pts receiving extended therapy.

Author

Posadas, E. M., primary, Tannir, N. M., additional, Wong, Y., additional, Ernstoff, M. S., additional, Kollmannsberger, C. K., additional, Qian, J., additional, Ansell, P. J., additional, McKeegan, E. M., additional, McKee, M. D., additional, Ricker, J. L., additional, Carlson, D. M., additional, and Michaelson, M. D., additional

Published
2011
Full Text
View/download PDF

120. Evaluation of second-line response to targeted therapy following progression on first-line cediranib, an oral pan-vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor (TKI), in advanced renal cell carcinoma (RCC).

Author

Richter, S., primary, Gan, H. K., additional, MacKenzie, M. J., additional, Hotte, S. J., additional, Mukherjee, S. D., additional, Kollmannsberger, C. K., additional, Ivy, S. P., additional, Fernandes, K., additional, Halford, R., additional, Massey, C., additional, Wang, L., additional, Moore, M. J., additional, and Sridhar, S. S., additional

Published
2011
Full Text
View/download PDF

121. The effect of low serum sodium on treatment outcome to vascular endothelial growth factor (VEGF)-targeted therapy in metastatic renal cell carcinoma: Results from a large international collaboration.

Author

Schutz, F. A., primary, Xie, W., additional, Heng, D. Y., additional, Donskov, F., additional, Wood, L., additional, Vaishampayan, U. N., additional, Tan, M., additional, MacKenzie, M. J., additional, Kollmannsberger, C. K., additional, and Choueiri, T. K., additional

Published
2011
Full Text
View/download PDF

128. A unified prognostic model for first- and second-line targeted therapy in metastatic renal cell carcinoma (mRCC): Results from a large international study.

Author

Heng, D. Y., primary, Xie, W., additional, Bjarnason, G. A., additional, Vaishampayan, U. N., additional, Donskov, F., additional, Wood, L., additional, Knox, J. J., additional, Tan, M., additional, Kollmannsberger, C. K., additional, Rini, B. I., additional, and Choueiri, T. K., additional

Published
2010
Full Text
View/download PDF

139. Prognostic factors for overall survival (OS) in patients with metastatic renal cell carcinoma (RCC) treated with vascular endothelial growth factor (VEGF)-targeted agents: Results from a large multicenter study

Author

Heng, D. Y., primary, Xie, W., additional, Regan, M. M., additional, Cheng, T., additional, North, S., additional, Knox, J. J., additional, Kollmannsberger, C., additional, McDermott, D., additional, Rini, B. I., additional, and Choueiri, T. K., additional

Published
2009
Full Text
View/download PDF

148. Activity of cediranib (AZD2171) in patients (pts) with previously untreated metastatic renal cell cancer (RCC). A phase II trial of the PMH Consortium

Author

Sridhar, S. S., primary, Mackenzie, M. J., additional, Hotte, S. J., additional, Mukherjee, S. D., additional, Kollmannsberger, C., additional, Haider, M. A., additional, Chen, E. X., additional, Wang, L., additional, Srinivasan, R., additional, Ivy, S. P., additional, and Moore, M. J., additional

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results